Format

Send to

Choose Destination
Pigment Cell Melanoma Res. 2019 May;32(3):474-478. doi: 10.1111/pcmr.12768. Epub 2019 Feb 10.

Biomarker discovery analysis: Alterations in p14, p16, p53, and BAP1 expression in nevi, cutaneous melanoma, and metastatic melanoma.

Author information

1
Department of Pathology, Stanford University Medical Center, Stanford, California.
2
Department of Dermatology, Stanford University Medical Center, Stanford, California.
3
Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.

KEYWORDS:

BAP1; biomarker; melanoma; p14ARF; p16; p53; prognosis

PMID:
30672662
DOI:
10.1111/pcmr.12768
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center